Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1984
Report date:
1984

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
; the study was conducted with mice (rat is the standard species, recommended in OECD guideline 401).
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
[1,3,8,16,18,24-hexabromo-2,4,9,10,11,15,17,22,23,25-decachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper
EC Number:
238-238-4
EC Name:
[1,3,8,16,18,24-hexabromo-2,4,9,10,11,15,17,22,23,25-decachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper
Cas Number:
14302-13-7
Molecular formula:
C32Br6Cl10CuN8
IUPAC Name:
[1,3,8,16,18,24-hexabromo-2,4,9,10,11,15,17,22,23,25-decachloro-29H,31H-phthalocyaninato(2-)-kappa~2~N~29~,N~31~]copper
Test material form:
solid: particulate/powder
Details on test material:
- Name of test material (as cited in study report): Lionol Green 6YK
- Analytical purity: no data given
- Substance type: fine green powder
- Storage condition of test material: at ambient temperature
Specific details on test material used for the study:
- Name of test material (as cited in study report): Lionol Green 6YK
- Analytical purity: no data given
- Substance type: fine green powder
- Storage condition of test material: at ambient temperature

Test animals

Species:
mouse
Strain:
other: HC/CFLP (ICI strain 1)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Hacking and Churchill Ltd., Huntingdon, Cambridgeshire, UK
- Age at study initiation: 4 - 6 weeks
- Weight at study initiation: 18 - 23 g
- Fasting period before study: overnight prior to and approx. 4 h after dosing
- Housing: allocation to cages within the treatment group; housing in plastic cages with sawdust bedding
- Diet: standard laboratory rodent diet (Scientific Feeds LAD 1 obtained from Special Diet Services Ltd., Witham, Essex, UK), ad libitum
- Water: ad libitum
- Acclimation period: minimum 6 days

ENVIRONMENTAL CONDITIONS
- Temperature: 20 - 23 °C
- Humidity: 64 %
- Air changes: 15 per hr
- Photoperiod: 12 hrs dark / 12 hrs light

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on oral exposure:
Concentration of the test material in vehicle:
- 40 % w/v suspension

- Amount of test material applied per gavage:
- 40 ml/kg bw for 16000 mg/kg bw

The control animals were treated with vehicle alone.
Doses:
0 and 16000 mg/kg bw
No. of animals per sex per dose:
5 animals per sex per dose.
Control animals:
yes
Details on study design:
Animals were observed soon after dosing; then at frequent intervals for the remainder of day 1, On subsequent days the animals were observed at least twice. Clinical signs were recorded at each observation.
All animals were observed for 14 days after dosing and the nature, severitx, approx. time of onset and duration of each toxic sign were recorded.
Individual body weights were recorded on day of dosing (day 1) and on days 8 and 15.
All animals were killed on day 15 and were subjected to a macroscopic post mortem examination.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 16 000 mg/kg bw
Mortality:
There were no mortalities.
Clinical signs:
other: Pilo-erection was observed following dosing in all treated mice with recovery apparently completed by day 2.
Gross pathology:
Terminal autopsy revealed no findings.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met